8-K: Centrus Q2 Net Income Dips Amid Revenue Decline

Centrus Energy Corp. reported a net income of $28.9 million on $154.5 million in revenue for Q2 2025, a decrease from the prior year, while successfully completing a key HALEU delivery and securing a new DOE contract phase.

Summary

• Net income for the three months ended June 30, 2025, was $28.9 million, down from $30.6 million in Q2 2024.
• Total revenue for Q2 2025 was $154.5 million, an 18% decrease from $189.0 million in Q2 2024.
• LEU segment revenue decreased by 26% to $125.7 million, primarily due to a decrease in the volume of uranium and SWU sold.
• Technical Solutions segment revenue increased by 48% to $28.8 million, driven by the HALEU production contract with the Department of Energy (DOE).
• Gross profit increased by 48% to $53.9 million in Q2 2025, up from $36.5 million in Q2 2024.
• Completed Phase 2 of the High-Assay, Low-Enriched Uranium (HALEU) Operation Contract on time, delivering 900 kilograms of HALEU to the Department of Energy.
• The Department of Energy exercised a portion of Phase 3 of the HALEU Operation Contract, valued at approximately $110.0 million through June 30, 2026.
• Consolidated cash balance stood at $833.0 million as of June 30, 2025.
• The company's backlog is $3.6 billion as of June 30, 2025, extending to 2040, with $2.7 billion in the LEU segment and $0.9 billion in the Technical Solutions segment.
• Raised approximately $114.0 million in net proceeds from an at-the-market equity offering during the quarter.

Sentiment

Score: 7

Explanation: While revenue and net income saw a decline, the company achieved significant operational milestones, including the successful delivery of HALEU and securing a new phase of the DOE contract. The substantial increase in gross profit, strong cash balance, and large backlog, coupled with a successful equity raise, indicate underlying strength and positive strategic progress despite the top-line dip. The decline in LEU revenue was offset by growth in Technical Solutions and improved margins.

Positives

• Gross profit increased by 48% to $53.9 million in Q2 2025, indicating improved margins.
• Technical Solutions segment revenue increased significantly by 48% to $28.8 million, primarily due to the HALEU production contract.
• Successfully completed Phase 2 of the HALEU Operation Contract on time, delivering 900 kilograms of HALEU to the Department of Energy.
• The Department of Energy exercised a portion of Phase 3 of the HALEU Operation Contract, valued at approximately $110.0 million through June 30, 2026, securing future revenue.
• Consolidated cash balance increased substantially to $833.0 million as of June 30, 2025, strengthening the balance sheet.
• Backlog remains robust at $3.6 billion, extending to 2040, providing long-term revenue visibility.
• Secured an additional $0.1 billion LEU contingent sales commitment in July 2025, further expanding potential future business.
• Successfully raised approximately $114.0 million in net proceeds from an at-the-market equity offering, providing capital for general corporate purposes.
• The average price of Separative Work Units (SWU) sold increased by 24%.

Negatives

• Net income decreased to $28.9 million in Q2 2025 from $30.6 million in Q2 2024.
• Total revenue decreased by $34.5 million (18%) to $154.5 million in Q2 2025 compared to Q2 2024.
• LEU segment revenue decreased by $43.9 million (26%) to $125.7 million, primarily due to a decrease in the volume of uranium and SWU sold.
• The volume of SWU sold decreased by 27%.
• Gross profit for the Technical Solutions segment decreased by $0.3 million (9%) to $3.2 million.
• Costs incurred subsequent to the Phase 2 extension for the HALEU Operation Contract have not yet been subject to a fee, as this portion remains undefinitized and subject to negotiation.

Risks

• Geopolitical conflicts and the imposition of sanctions or other measures (e.g., bans, tariffs) by governments or organizations could impact financial position or ability to obtain, deliver, transport, or sell LEU/SWU/natural uranium hexafluoride, especially concerning the TENEX Supply Contract.
• Laws or government measures banning, delaying, or restricting imports of Russian LEU into the United States, including the Import Ban Act effective August 11, 2024, subject to waivers.
• Laws or government measures banning, delaying, or restricting transactions with Rosatom or its subsidiaries, including TENEX.
• Laws or government measures banning, delaying, or restricting exports of Russian LEU from Russia to the United States or any U.S. entity, such as Russian Federal Decree No. 1544.
• Potential inability to secure additional U.S. government waivers from the Import Ban Act in a timely manner or at all.
• TENEX's refusal, prohibition, or inability to deliver LEU due to sanctions, inability to receive payments, or failure to secure export licenses from Russian authorities.
• Disputes with third parties, including contractual counterparties, if timely LEU deliveries are not received under the TENEX Supply Contract.
• Dependence on others, such as TENEX and Orano, and other suppliers (transporters, fabricators, converters) for goods and services, potentially impacting liquidity.
• Ability to sell, transport, or deliver procured LEU, and the impacts of sanctions or limitations on imports, including those imposed under the 1992 Russian Suspension Agreement, Import Ban Act, and Russian Decree.
• Increasing quantities of LEU being imported into the United States from China and the impact on future LEU or SWU sales or ability to finance enrichment capacity build-out.
• Changes in laws, tariffs, or other government measures that would lift, lower, or relax restrictions on LEU importation from Russia or other countries.
• Inability to sell Russian LEU allowed for import in 2026 or 2027, even with waivers, if customers have filled their fuel needs.
• Uncertainty regarding whether or when government funding or demand for HALEU for government or commercial uses will materialize and at what level.
• Risks regarding funding for continuation and deployment of the American Centrifuge technology.
• Ability to perform and absorb costs under the HALEU Operation Contract, obtain new contracts and funding, or perform under other agreements.
• Not obtaining the full benefit of the HALEU Operation Contract, or inability/disallowance to operate the HALEU enrichment facility after contract completion, or the output not being available as a future supply source.
• Existing or new trade barriers, and contract terms, that limit the ability to procure LEU for, or sell, transport, or deliver LEU to, customers.
• Pricing trends and demand in the uranium and enrichment markets and their impact on profitability.
• Movement and timing of customer orders.
• Significant competition from major LEU producers who may be less cost-sensitive or are wholly or partially government-owned.
• Limited ability to compete in foreign markets due to policies favoring indigenous suppliers.
• Revenue is largely dependent on largest customers.
• Backlog uncertainty concerning customer actions under current contracts and in future contracting attributable to market conditions, global events, or lack of current production capability.
• Natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan, on the nuclear industry and on business.
• Financial difficulties experienced by customers or suppliers, including possible bankruptcies or insolvencies.
• Pandemics, endemics, and other health crises.
• Impact and potential extended duration of a supply/demand imbalance in the market for LEU.
• DOE not issuing any major task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• The company not winning a task order under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract to expand the capacity of the American Centrifuge plant.
• DOE not providing an adequate share of appropriated funding to the company under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• Inability to secure financing to expand the plant for LEU or HALEU or expand it to a commercially viable level.
• DOE not exercising additional options under Phase 3 of the HALEU Operation Contract or awarding a third party to continue it.
• Inability to increase capacity for HALEU or LEU in a timely manner to meet market demand or contractual obligations.
• DOE not awarding any contracts to the company in response to future proposals.
• Reliance on the only firm that has the necessary permits and capability to transport LEU from Russia to the United States and that firm's ability to maintain those permits and capabilities or secure additional permits.
• A government shutdown or lack of funding could result in program cancellations, disruptions, and/or stop work orders, and could limit the U.S. government's ability to make timely payments.
• Changes to the U.S. government's appropriated funding levels for the HALEU Operation Contract due to changes in U.S. government policy or other reasons.
• Uncertainty regarding the ability to commercially deploy competitive enrichment technology.
• Potential for demobilization or termination of the HALEU Operation Contract.
• Inability to timely complete the work that the company is obligated to perform.
• The government's inability to satisfy its obligations, including supplying government furnished equipment necessary for HALEU production and processing security clearance applications.
• Inability to obtain the government's approval to extend the term of, or the scope of permitted activities under, the lease with the DOE in Piketon, Ohio.
• Security, including cybersecurity, incidents that may impact business operations, including incidents related to ongoing geopolitical conflicts.
• Inability to perform fixed-price and cost-share contracts such as the HALEU Operation Contract, including the risk that costs could be higher than expected and compliance with stringent government contractual requirements.
• Inability to attract qualified employees necessary for the potential expansion of operations in Oak Ridge, Tennessee, or Piketon, Ohio.
• Long-term liabilities, including defined benefit pension plan obligations and postretirement health and life benefit obligations.
• Risks related to the 2.25% Convertible Senior Notes maturing in 2030.
• Revenue and operating results fluctuating significantly from quarter to quarter, and in some cases, year to year.
• Impact of financial market conditions on business, liquidity, prospects, pension assets, and insurance facilities.
• The company's capital concentration.
• Value of intangible assets related to LEU segments backlog and customer relationships.
• Decisions made by Class B Common Stock stockholders regarding their investment in the company, including decisions based upon factors unrelated to the company's performance.
• A small number of holders of Class A Common Stock may exert significant influence over the direction of the company, with interests not aligned with other Class A stockholders.
• Risks related to the use of net operating losses (NOLs) carryforwards and net unrealized built-in losses (NUBILs) to offset future taxable income, and the ability to generate taxable income to utilize them.
• Failures or security, including cybersecurity, breaches of information technology systems.
• Inability to attract and retain key personnel.
• Inability to obtain new business opportunities or achieve market acceptance of products and services, or that products or services provided by others will render products or services obsolete or noncompetitive.
• Actions, including investigations, reviews, or audits, that may be taken by the U.S. government, the Russian government, or other governments that could affect the ability to perform under contractual obligations or the ability of sources of supply to perform.
• Inability to perform and receive timely payment under agreements with the DOE or other government agencies, including risks related to ongoing funding by the government and potential audits.
• How aligned the company may be, or perceived to be, with any political party, administration, or its policies.
• Changes or termination of agreements with the U.S. government or other counterparties, or the exercise of contract remedies by such counterparties.
• The competitive environment for products and services.
• Changes in the nuclear energy industry.
• The competitive bidding process associated with obtaining contracts, including government contracts.
• Potential strategic transactions that could be difficult to implement, disrupt business, or change the business profile significantly.
• The outcome of legal proceedings and other contingencies (including lawsuits and government investigations or audits).
• Impact of, or changes to, government regulation and policies or interpretation of laws or regulations, including by the U.S. Securities and Exchange Commission, the DOE, the U.S. Department of Commerce, and the U.S. Nuclear Regulatory Commission.
• The recent U.S. federal government administration's reliance on executive orders to implement regulatory or trade policy and objectives, which could exacerbate regulatory or financing unpredictability.
• Accidents during the transportation, handling, or processing of toxic hazardous or radioactive material that may pose a health risk, cause property or environmental damage, or result in precautionary evacuations, and lead to claims.
• Claims and litigation arising from past activities at sites currently operated or no longer operated, including the Paducah, Kentucky, and Portsmouth, Ohio, gaseous diffusion plants.

Future Outlook

Centrus is continuing preparations for future enrichment build-out. The company is now producing HALEU under Option 1a of the HALEU Operation Contract, with the DOE having exercised this option extending the period of performance to June 30, 2026. There is a strong consensus among nuclear utilities and policymakers for an additional enricher in the U.S. market, which Centrus aims to fulfill as a publicly-traded American source of enrichment. The company's ability to expand LEU production capacity at Piketon, Ohio, and secure additional HALEU/LEU contracts depends on securing substantial public and private investment and winning future task orders.

Management Comments

• "We delivered another strong quarter of revenue and margins while successfully continuing our preparations ahead of our future enrichment build-out."
• "We achieved yet another important operational milestone this quarter, contractually delivering 900 kilograms of HALEU to the Department of Energy."
• "By successfully reaching our contractual production target, we have further confirmed our technology’s ability to operate as expected and predictably deliver results for our customers and for the nation."
• "The Department of Energy also initiated Phase 3 by exercising an option to extend our competitively-awarded contract."
• "There is a strong consensus among nuclear utilities and policymakers that an additional enricher is required to bring new supply and new competition to the U.S. market, which has been long dominated by foreign, state-owned enterprises."
• "Centrus is proud to offer a publicly-traded, American source of enrichment."

Industry Context

The filing highlights a strong consensus among nuclear utilities and policymakers for the need for an additional enricher in the U.S. market to counter the dominance of foreign, state-owned enterprises. Centrus positions itself as a key American source of enrichment, particularly with its HALEU production, which is crucial for advanced reactors and national priorities. The company's efforts align with broader trends of energy security and reducing reliance on foreign nuclear fuel sources, especially given geopolitical risks and import bans on Russian LEU.

Comparison to Industry Standards

• The filing states a general consensus among nuclear utilities and policymakers that an additional enricher is required to bring new supply and competition to the U.S. market, which has been long dominated by foreign, state-owned enterprises. However, it does not provide specific comparable companies, projects, or results to benchmark Centrus's performance against.

Stakeholder Impact

• Shareholders: Experienced dilution from the at-the-market equity offering, but benefit from increased cash balance and strategic progress in HALEU production and new contracts, which could be positive long-term. The net income decrease might be a short-term concern.
• Customers: Benefit from the continued supply of nuclear fuel (LEU) and HALEU, with new contract phases ensuring future availability, especially for advanced reactors.
• Employees: Potential for expansion of operations in Oak Ridge, Tennessee, or Piketon, Ohio, if financing and contracts materialize, leading to job opportunities.
• Department of Energy (DOE): The successful delivery of HALEU and continuation of the HALEU Operation Contract supports national priorities for advanced reactors and energy security.

Next Steps

• Continue preparations ahead of future enrichment build-out.
• Produce HALEU under Option 1a of the HALEU Operation Contract through June 30, 2026.
• Potentially exercise Option 1b for HALEU Operation Contract from July 1, 2026, through June 30, 2028.
• Secure substantial public and private investment for potential construction of LEU production capacity at the Piketon, Ohio facility.
• Enter into definitive agreements for contingent LEU sales commitments.
• Potentially win task orders under HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract to expand American Centrifuge plant capacity.

Key Dates

Recommendation

While Centrus reported a decline in net income and total revenue, the underlying operational performance shows strength, particularly in the Technical Solutions segment and gross profit. The successful delivery of HALEU and the securing of a significant Phase 3 DOE contract, coupled with a robust cash position and substantial backlog, indicate positive strategic momentum. However, the top-line revenue decline in the LEU segment and the ongoing reliance on securing further investments for expansion, along with geopolitical risks related to supply chains, suggest a 'hold' position. The company is making progress on key strategic initiatives, but the financial results are mixed, warranting observation rather than an immediate buy or sell.

Keywords

Nuclear fuel, HALEU, LEU, Uranium enrichment, Centrus Energy, DOE contract, Advanced reactors, Energy security, Nuclear power, Piketon Ohio, American Centrifuge